Skip to content
HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Watch a genetically modified CAR T cell bind to a target called CD19 on a cancerous B cell. This is what happens inside the body of a patient who receives CAR T-cell therapy.
Related Centers and Programs:
Cancer Immunotherapy Program, Cellular Therapy and Transplant Section, Cancer Center, Relapsed Leukemia and Lymphoma Program
In CAR T-cell therapy, immune cells called T cells are genetically modified to recognize cancerous B cells.
Here’s what you can expect throughout the CAR T-cell therapy experience.
This is a child-friendly explanation of how cancer immunotherapy, or T-cell therapy, works.